Current Value
$1.381 Year Return
Current Value
$1.381 Year Return
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| GNOM | 61.65% | $44.57M | 0.5% |
| ARKG | 61.23% | $1.02B | 0.75% |
| IWC | 58.45% | $818.14M | 0.6% |
| XBI | 56.71% | $4.82B | 0.35% |
| IBB | 53.99% | $5.26B | 0.45% |
| IWM | 53.88% | $63.72B | 0.19% |
| VTWO | 53.83% | $12.52B | 0.07% |
| IWO | 53.27% | $11.60B | 0.24% |
| GSSC | 53.25% | $561.54M | 0.2% |
| PBE | 52.83% | $223.19M | 0.58% |
| IWN | 52.30% | $10.96B | 0.24% |
| SCHA | 52.04% | $17.26B | 0.04% |
| PRFZ | 51.88% | $2.36B | 0.34% |
| VIOV | 51.44% | $1.27B | 0.1% |
| ARKK | 51.31% | $6.85B | 0.75% |
| FBT | 50.97% | $1.01B | 0.54% |
| IJR | 50.80% | $79.13B | 0.06% |
| SPSM | 50.71% | $11.30B | 0.03% |
| IJS | 50.62% | $6.06B | 0.18% |
| VIOO | 50.59% | $2.85B | 0.1% |
Yahoo
The market has stayed flat over the past seven days, yet it is up 9.9% over the past year, with earnings forecasted to grow by 15% annually. In such a landscape, identifying stocks with strong financials becomes crucial for investors seeking value and growth opportunities. Penny stocks, despite their somewhat outdated name, continue to be relevant as they often represent smaller or newer companies that can offer significant potential when backed by solid fundamentals.
Yahoo
BERKELEY, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel Haurwitz, PhD, Caribou’s president and chief executive officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 4th at 9:20 AM EDT. For more information and a link to the webcast, visit the Events page on Caribou’s website. Webcasts will be available on the Caribou we
Yahoo
The U.S. stock market has experienced a slight downturn, following a period of gains for the S&P 500, as investors digest recent economic developments and corporate earnings. In this context, penny stocks continue to capture attention as they represent smaller or newer companies that can offer unique investment opportunities. While the term might seem outdated, these stocks still hold potential for growth when backed by strong financials and solid fundamentals.
Yahoo
Caribou Biosciences (CRBU) delivered earnings and revenue surprises of 0% and 5.88%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Yahoo
-- Two robust clinical datasets from CB-010 and CB-011 expected to be disclosed in H2 2025 -- -- $212.5 million in cash, cash equivalents, and marketable securities expected to fund the Company’s current operating plan into H2 2027 -- BERKELEY, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today reported financial results for the first quarter 2025 and provided a business update for its
Yahoo
BERKELEY, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel Haurwitz, PhD, Caribou’s president and chief executive officer, will participate in a fireside chat at the BofA Securities 2025 Health Care Conference on May 13th at 2:35 PM PDT. For more information and a link to the webcast, visit the Events page on Caribou’s website. Webcasts will be available on the Carib
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -38.29% | $296.22M | 1.43% |
| VIXY | -33.03% | $164.54M | 0.85% |
| TAIL | -28.63% | $99.63M | 0.59% |
| IVOL | -16.24% | $347.03M | 1.02% |
| BSMW | -14.47% | $107.45M | 0.18% |
| SPTS | -12.15% | $5.80B | 0.03% |
| XHLF | -12.04% | $1.73B | 0.03% |
| XONE | -11.96% | $625.28M | 0.03% |
| LDUR | -11.89% | $929.65M | 0.5% |
| CTA | -11.04% | $1.06B | 0.76% |
| FXY | -10.80% | $816.38M | 0.4% |
| VGSH | -10.72% | $22.80B | 0.03% |
| SMMU | -10.25% | $892.02M | 0.35% |
| UTWO | -10.14% | $379.52M | 0.15% |
| STPZ | -10.01% | $450.47M | 0.2% |
| IBTJ | -9.85% | $688.19M | 0.07% |
| IBTH | -9.64% | $1.62B | 0.07% |
| FTSD | -9.57% | $231.81M | 0.25% |
| IBTK | -9.56% | $448.89M | 0.07% |
| ULST | -9.51% | $654.75M | 0.2% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| VCRB | -0.10% | $3.13B | 0.1% |
| PSQA | 0.11% | $35.44M | 0.2% |
| FXE | 0.12% | $568.94M | 0.4% |
| MBB | 0.19% | $39.33B | 0.04% |
| ISTB | 0.19% | $4.44B | 0.06% |
| MUST | -0.21% | $439.10M | 0.23% |
| UBND | 0.21% | $1.02B | 0.4% |
| SPTL | -0.22% | $11.44B | 0.03% |
| CMF | -0.22% | $3.59B | 0.08% |
| CERY | -0.27% | $458.93M | 0.28% |
| SHAG | 0.32% | $43.05M | 0.12% |
| EUSB | -0.33% | $735.36M | 0.12% |
| CGSD | 0.34% | $1.32B | 0.25% |
| SCHP | 0.39% | $12.99B | 0.03% |
| SHV | -0.42% | $20.64B | 0.15% |
| SCHQ | -0.45% | $758.74M | 0.03% |
| MUB | -0.52% | $38.64B | 0.05% |
| GCOR | 0.55% | $588.95M | 0.08% |
| JPST | 0.56% | $31.90B | 0.18% |
| TLT | 0.56% | $48.41B | 0.15% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| KVUE | -0.01% | $40.13B | +14.15% | 3.92% |
| ES | -0.04% | $23.68B | +12.46% | 4.54% |
| GFI | -0.07% | $21.56B | +57.55% | 2.31% |
| PG | -0.31% | $377.94B | -1.61% | 2.53% |
| TW | 0.43% | $29.58B | +30.05% | 0.32% |
| AWK | 0.44% | $27.36B | +9.65% | 2.21% |
| TSN | 0.52% | $20.06B | +1.50% | 3.46% |
| LRN | 0.53% | $5.99B | +100.06% | 0.00% |
| AU | -0.53% | $23.49B | +78.98% | 2.23% |
| BCE | 0.53% | $21.07B | -27.36% | 10.97% |
| GIS | 0.58% | $29.20B | -14.66% | 4.47% |
| MVO | -0.65% | $66.47M | -37.17% | 21.45% |
| MKTX | 0.68% | $8.22B | +9.03% | 1.38% |
| KR | 0.70% | $46.43B | +38.38% | 1.85% |
| ETR | 0.74% | $35.03B | +54.09% | 4.33% |
| HSY | 0.75% | $35.88B | -3.63% | 3.10% |
| FRO | -0.77% | $3.78B | -32.58% | 7.74% |
| COR | 0.80% | $56.44B | +30.86% | 0.74% |
| TMUS | 0.81% | $269.58B | +33.04% | 1.38% |
| DRD | -0.82% | $1.18B | +51.33% | 2.03% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CRSP | 61.63% | $4.46B | -4.14% | 0.00% |
| FATE | 55.75% | $128.39M | -64.56% | 0.00% |
| BEAM | 54.91% | $2.00B | -15.33% | 0.00% |
| RXRX | 52.83% | $2.12B | -29.12% | 0.00% |
| NTLA | 52.83% | $1.11B | -53.25% | 0.00% |
| MGNX | 52.71% | $87.06M | -67.14% | 0.00% |
| SFBS | 49.52% | $4.48B | +32.92% | 1.58% |
| CDXS | 49.43% | $232.79M | -2.43% | 0.00% |
| KN | 49.18% | $1.57B | +6.47% | 0.00% |
| SYRE | 49.01% | $935.48M | -39.83% | 0.00% |
| COHU | 48.34% | $953.77M | -38.54% | 0.00% |
| PACB | 47.72% | $447.13M | +14.62% | 0.00% |
| CTS | 47.62% | $1.33B | -10.75% | 0.36% |
| DNLI | 47.46% | $2.16B | -30.05% | 0.00% |
| SITE | 47.37% | $5.78B | +9.30% | 0.00% |
| SCL | 47.26% | $1.33B | -29.11% | 2.60% |
| ILMN | 47.07% | $15.88B | -4.69% | 0.00% |
| ABCL | 46.72% | $1.12B | +38.38% | 0.00% |
| ZNTL | 46.67% | $89.22M | -64.37% | 0.00% |
| TEX | 46.50% | $3.28B | -7.88% | 1.35% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CBOE | -19.75% | $24.23B | +35.36% | 1.09% |
| CME | -14.89% | $99.39B | +40.68% | 3.86% |
| BTCT | -13.62% | $25.56M | +61.14% | 0.00% |
| ED | -11.58% | $36.00B | +12.64% | 3.34% |
| EXC | -10.79% | $43.33B | +23.58% | 3.62% |
| DUK | -9.52% | $90.99B | +17.25% | 3.56% |
| T | -8.35% | $203.71B | +51.55% | 3.92% |
| AQB | -7.84% | $2.96M | -53.35% | 0.00% |
| BULL | -7.12% | $6.47B | +25.76% | 0.00% |
| CNP | -6.75% | $23.35B | +17.94% | 2.36% |
| HUSA | -6.66% | $19.66M | -19.53% | 0.00% |
| TEF | -6.59% | $30.08B | +25.41% | 6.16% |
| PM | -6.55% | $273.81B | +73.45% | 3.06% |
| K | -6.14% | $27.76B | +41.17% | 2.85% |
| CL | -6.01% | $74.88B | -3.64% | 2.19% |
| VHC | -5.88% | $48.19M | +108.24% | 0.00% |
| FTS | -5.27% | $23.62B | +20.13% | 3.70% |
| NEUE | -5.11% | $61.24M | +29.92% | 0.00% |
| NOC | -4.82% | $71.81B | +14.14% | 1.69% |
| SO | -4.60% | $100.18B | +17.28% | 3.18% |
